Novo Nordisk stock rose 2.6% after withdrawing from a $10 billion bidding war for Metsera that investors viewed as too ...

Shares in Novo Nordisk NOVOb.CO rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S.

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Pedersen COPENHAGEN (Reuters) -Shares in Novo Nordisk rose on Monday after the Wegovy maker lost out to Pfizer in a $10 ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

Investing.com -- Metsera Inc. (NASDAQ:MTSR) stock tumbled as much as 16% to $70.15 in premarket trading Monday after Novo Nordisk A/S (NYSE:NVO) abandoned its pursuit of the US weight-loss drug ...

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping ...

Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House ...